REVIEW

EUROCAT: 25 years of European surveillance of congenital anomalies

H Dolk

Correspondence to:
Correspondence to:
Professor Dolk
EUROCAT Project Leader, Epidemiology and Health Services Research, University of Ulster at Jordanstown, Shore Rd, Newtownabbey BT37 OQB, UK; h.dolk{at}ulster.ac.uk

The surveillance of congenital anomalies serves two main purposes: to facilitate the identification of teratogenic (malformation causing) exposures and to assess the impact of primary prevention and prenatal screening policy and practice at a population level. EUROCAT, the European network of population based registers for the epidemiological surveillance of congenital anomalies, now covers 1.2 million births per year, a quarter of births in Europe. The added value of European collaboration is particularly great for congenital anomalies, coming from the opportunity to pool data, to compare data between regions and countries, to give a common response to European public health questions, and to share expertise and resources, including computing tools. EUROCAT provides essential epidemiological information on congenital anomalies in Europe, facilitates the early warning of teratogenic exposures, evaluates the effectiveness of primary prevention, assesses the impact of developments in prenatal screening, acts as an information and resource centre regarding clusters, provides a ready collaborative network and infrastructure for research, and acts as a catalyst for the setting up of registries throughout Europe.

Keywords: congenital anomalies; epidemiology; surveillance; Europe; prevention

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Pedersen, L. H., Henriksen, T. B., Vestergaard, M., Olsen, J., Bech, B. H. (2009). Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 339: b3569-b3569 [Abstract] [Full Text]  
• Dolk, H., Jentink, J., Loane, M., Morris, J., de Jong-van den Berg, L.T.W., On behalf of The EUROCAT Antiepileptic Drug Workin, (2008). Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?. Neurology 71: 714-722 [Abstract] [Full Text]